Nuveen Asset Management, LLC Acumen Pharmaceuticals, Inc. Transaction History
Nuveen Asset Management, LLC
- $340 Billion
- Q4 2024
A detailed history of Nuveen Asset Management, LLC transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 78,446 shares of ABOS stock, worth $165,521. This represents 0.0% of its overall portfolio holdings.
Number of Shares
78,446
Previous 78,446
-0.0%
Holding current value
$165,521
Previous $194,000
30.93%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ABOS
# of Institutions
72Shares Held
38.8MCall Options Held
31.5KPut Options Held
0-
Ra Capital Management, L.P. Boston, MA14.9MShares$31.5 Million0.38% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$7.21 Million1.28% of portfolio
-
Franklin Resources Inc San Mateo, CA3.08MShares$6.49 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$4.55 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.95MShares$4.11 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $85.5M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...